Replies to post #209672 on Biotech Values

[dewophile]

I don't follow the company at all. I'll be somewhat surprised if the drug works. If this trial has a positive readout it won't necessarily translate in centers where there are much higher baseline success rates (note the top centers in the US have success rates north of 55-60% in good prognosis patients already)